Glycyrrhizin Suppresses the Growth of Human NSCLC Cell Line HCC827 by Downregulating HMGB1 Level
Authors:
Open Access
- 15 January 2018
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-7
Abstract
Lung cancer has very high mortality and glycyrrhizin was found to significantly inhibit the growth of lung cancer cells in vitro and tissues in mice. However, the detailed inhibitory role of glycyrrhizin in the growth of lung cancer is still unclear. In this study, we first found that glycyrrhizin inhibited the growth of lung tumor in PDX mice. And high level of HMGB1 promoted the migration and invasion of lung cancer cells, which was suppressed by glycyrrhizin. Moreover, glycyrrhizin reduced the activity of JAK/STAT signaling pathway, which is the upstream regulator of HMGB1. Therefore, this study revealed a potential mechanism by which glycyrrhizin can inhibit the progression of lung cancer.Keywords
Funding Information
- Foundation of Jiangsu Provincial Commission of Health and Family Planning (QMRC2016363, Z201627, KC14SH009, (2016)-1903)
- Key Talents of Medical Science in Jiangsu Province (QMRC2016363, Z201627, KC14SH009, (2016)-1903)
- Xuzhou Administration of Science & Technology (QMRC2016363, Z201627, KC14SH009, (2016)-1903)
- 333 high-level talents of Jiangsu Province (QMRC2016363, Z201627, KC14SH009, (2016)-1903)
This publication has 38 references indexed in Scilit:
- Lung cancer biomarkers: State of the artJournal of Carcinogenesis, 2013
- Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant MesotheliomaCancer Research, 2012
- Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC‐803 gastric cancer cellsCell Biochemistry and Function, 2011
- HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor RegressionPLOS Medicine, 2009
- Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine ActivitiesChemistry & Biology, 2007
- High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenalNature Reviews Immunology, 2005
- The JAK/STAT signaling pathwayJournal of Cell Science, 2004
- A Road Map for Those Who Don't Know JAK-STATScience, 2002
- Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosisHepatology Research, 2000
- Glycyrrhizic acid inhibits virus growth and inactivates virus particlesNature, 1979